A significant reduction in total cholesterol , low-density lipoprotein , and white blood cell count was observed during the study in the rosuvastatin group ( total cholesterol , from @ to @ mmol/l , P = @ ; low-density lipoprotein , from @ to @ mmol/l , P = @ ; white blood cell count , from @ to @/l , P = @ ) , but not in the pravastatin group .